Dean H. Bergy, Director at RTI Biologics, Inc. (RTIX), bought 8,000 shares at $2.50 ($20K) on 2010-11-16, disclosed to the SEC on 2010-11-16.
Open-market purchase of $20k RTIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 2,500 | $6K | 31.3% |
| 2 | $2.50 | 5,500 | $14K | 68.8% |
| Total | $2.50 avg | 8,000 | $20K | 100% |